Create Alert
Watchlist

Balaxi Pharmaceuticals

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹270Cr
ROE10.82%
P/E Ratio(TTM)10.77
EPS(TTM)4.54
P/B Ratio1.17
Dividend Yield0.00%
Industry P/E35.90
Book Value41.97
Debt to Equity0.23
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Balaxi Pharma

Balaxi Pharmaceuticals Limited is an India-based intellectual property research (IPR) pharmaceutical company. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It has a portfolio across multiple therapeutic segments, stock & sell models, and supplying branded and generic medicines. The Company is offerings more than 300 products across multiple therapeutic areas, including Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhoea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents and Laxative. Its consumer products include Nice 45 G, Guloso 45 G, Snax! 42 G, Doce E Sal 42 G, Yumm 75 G and Boadent.;
Parent OrganisationBalaxi Pharmaceuticals Limited
Managing DirectorMr. Ashish Maheshwari
NSE SymbolBALAXI

Shareholding Pattern

Apr '24
Jun '24
Sep '24
Dec '24
Mar '25
Promoters
65.99%
Retail And Others
17.96%
Foreign Institutions
16.02%
Other Domestic Institutions
0.02%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
156.15
Wockhardt
NA
(0.00%)
-2458.24
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.38
Emcure Pharmaceuticals
NA
(0.00%)
38.09